FMR LLC

Holdings History for Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Symbol: CNTA on Nasdaq
Investment type: Equity / Ordinary shares, nominal value 0.002 GBP per share
Latest Disclosed Shares Owned: 10,999,793 shares
Security Ownership %: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share (CNTA)

06 Feb 2026 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,999,793 shares of Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share (CNTA). This represents 12% ownership of the company. In their previous filing dated 05 Feb 2026, FMR LLC had reported owning 8,894,939 shares, indicating an increase of +24%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
FMR LLC	12%	+23%	$275,104,823	10,999,793	+2,104,854	+24%	$25.01	13G/A	30 Jan 2026	06 Feb 2026, 13:11
FMR LLC	9.9%	+41%	$222,462,424	8,894,939	+2,617,696	+42%	$25.01	13G/A	31 Dec 2025	05 Feb 2026, 13:20
FMR LLC	7%		$152,223,143	6,277,243			$24.25	13G	30 Sep 2025	05 Nov 2025, 11:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$224,138,094	8,961,939	+2,684,696	+43%	$25.01	Q4 2025
30 Sep 2025	0.01%	+0%	$152,223,143	6,277,243	+2,451,049	+64%	$24.25	Q3 2025
30 Jun 2025	0%	0%	$50,276,189	3,826,194	0		$13.14	Q2 2025
31 Mar 2025	0%	+0%	$55,020,670	3,826,194	+174,600		$14.38	Q1 2025
31 Dec 2024	0%	+0%	$61,164,200	3,651,594	+735,100	+25%	$16.75	Q4 2024
30 Sep 2024	0%	+0%	$46,634,739	2,916,494	+129,300	+4.6%	$15.99	Q3 2024
30 Jun 2024	0%	0%	$25,168,362	2,787,194	0		$9.03	Q2 2024
31 Mar 2024	0%	0%	$31,495,292	2,787,194	0		$11.30	Q1 2024
31 Dec 2023	0%	0%	$22,186,064	2,787,194	0		$7.96	Q4 2023
30 Sep 2023	0%	0%	$18,033,145	2,787,194	0		$6.47	Q3 2023
30 Jun 2023	0%	+0%	$17,252,731	2,787,194	+1,556,285	+126%	$6.19	Q2 2023
31 Mar 2023	0%	0%	$4,739,000	1,230,909	0		$3.85	Q1 2023
31 Dec 2022	0%	+0%	$3,815,818	1,230,909	+522,118	+74%	$3.10	Q4 2022
30 Sep 2022	0%	+0%	$2,849,000	708,791	+698,491	+6781%	$4.02	Q3 2022
30 Jun 2022	0%	0%	$50,000	10,300	0		$4.85	Q2 2022
31 Mar 2022	0%	-0%	$92,000	10,300	-84,000	-89%	$8.93	Q1 2022
31 Dec 2021	0%	-0%	$1,062,000	94,300	-268,437	-74%	$11.26	Q4 2021
30 Sep 2021	0%	-0%	$6,058,000	362,737	-427,263	-54%	$16.70	Q3 2021
30 Jun 2021	0%	+0%	$17,546,000	790,000	+790,000	NEW	$22.21	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.